AG˹ٷ

STOCK TITAN

[144] Nova Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for NVMI shows a proposed sale of 2,220 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of 526,495.20 and an approximate sale date of 09/03/2025 on Nasdaq. The filing identifies the securities were acquired as Restricted Stock Units on 09/01/2021 (7,000), 09/01/2022 (4,875), 09/01/2023 (2,250) and 09/01/2024 (766). Total outstanding shares listed are 29,278,401. The filer certifies they are not aware of any undisclosed material adverse information and no sales in the past three months are reported.

Avviso Form 144 per NVMI indica una proposta di vendita di 2.220 azioni ordinarie tramite Oppenheimer & Co. Inc., con un valore di mercato complessivo di 526.495,20 e una data di vendita approssimativa del 03/09/2025 su Nasdaq. La comunicazione specifica che i titoli sono stati acquisiti come Restricted Stock Units il 01/09/2021 (7.000), il 01/09/2022 (4.875), il 01/09/2023 (2.250) e il 01/09/2024 (766). Le azioni in circolazione totali sono 29.278.401. Il dichiarante certifica di non essere a conoscenza di informazioni materiali avverse non divulgate e non segnala vendite negli ultimi tre mesi.

Aviso Form 144 para NVMI muestra una propuesta de venta de 2.220 acciones ordinarias a través de Oppenheimer & Co. Inc., con un valor de mercado agregado de 526.495,20 y una fecha de venta aproximada del 03/09/2025 en Nasdaq. La presentación identifica que los valores fueron adquiridos como Restricted Stock Units el 01/09/2021 (7.000), 01/09/2022 (4.875), 01/09/2023 (2.250) y 01/09/2024 (766). Las acciones en circulación totales son 29.278.401. El declarante certifica que no tiene conocimiento de información material adversa no divulgada y no informa ventas en los últimos tres meses.

NVMI� 대� Form 144 통지� Oppenheimer & Co. Inc.� 통해 2,220 보통주를 매도� 예정임을 보여주며, � 시가총액은 526,495.20이고 대략적� 매각 예정일은 2025� 9� 3�(Nasdaq)입니�. 제출서에� 해당 증권� Restricted Stock Units� 취득되었음이 명시되어 있으� 취득일은 2021-09-01(7,000), 2022-09-01(4,875), 2023-09-01(2,250), 2024-09-01(766)입니�. � 발행주식수는 29,278,401주입니다. 제출인은 공개되지 않은 중대� 불리� 정보가 없음� 증명하며 지� 3개월� 매도� 보고하지 않았습니�.

Avis Form 144 pour NVMI indique une vente proposée de 2 220 actions ordinaires via Oppenheimer & Co. Inc., pour une valeur de marché globale de 526�495,20 et une date de vente approximative au 03/09/2025 sur le Nasdaq. Le dépôt précise que les titres ont été acquis en tant que Restricted Stock Units le 01/09/2021 (7 000), le 01/09/2022 (4 875), le 01/09/2023 (2 250) et le 01/09/2024 (766). Le nombre total d'actions en circulation est de 29 278 401. Le déclarant certifie ne pas avoir connaissance d'informations défavorables matérielles non divulguées et ne signale aucune vente au cours des trois derniers mois.

Form 144-Mitteilung für NVMI zeigt einen geplanten Verkauf von 2.220 Stammaktien über Oppenheimer & Co. Inc. mit einem Gesamtmarktwert von 526.495,20 und einem ungefähren Verkaufsdatum am 03.09.2025 an der Nasdaq. Die Einreichung gibt an, dass die Wertpapiere am 01.09.2021 (7.000), 01.09.2022 (4.875), 01.09.2023 (2.250) und 01.09.2024 (766) als Restricted Stock Units erworben wurden. Die insgesamt ausstehenden Aktien betragen 29.278.401. Der Einreicher bestätigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und meldet keine Verkäufe in den letzten drei Monaten.

Positive
  • Filing discloses use of a registered broker: Oppenheimer & Co. Inc.
  • Acquisition history provided showing securities came from Restricted Stock Units on specific dates
  • Filer attests there is no known undisclosed material adverse information
  • No securities sold by the filer in the past three months per the form
Negative
  • Proposed sale of 2,220 ordinary shares (aggregate market value 526,495.20) is being reported
  • The sale will occur against a reported 29,278,401 shares outstanding, which may be considered insider selling activity

Insights

TL;DR Routine insider sale notice: small block relative to outstanding shares, transparent disclosure.

The filing documents a proposed sale of 2,220 ordinary shares via a registered broker with a stated aggregate market value of 526,495.20 and an approximate trade date of 09/03/2025. Acquisition details show these shares originated from Restricted Stock Units granted across 2021�2024. There were no reported sales in the prior three months and the filer attests to no undisclosed material adverse information. For investors, this is a standard compliance disclosure rather than a material corporate event.

TL;DR Proper insider reporting consistent with Rule 144; disclosure and attestations are present.

The form contains the required broker, share count, market value, acquisition dates and nature of acquisition (RSUs). The attestation about material information and indication of no prior three-month sales align with disclosure obligations. The sale size (2,220 shares) should be viewed in the context of reported outstanding shares (29,278,401), and the document itself reflects governance and compliance processes rather than a governance concern.

Avviso Form 144 per NVMI indica una proposta di vendita di 2.220 azioni ordinarie tramite Oppenheimer & Co. Inc., con un valore di mercato complessivo di 526.495,20 e una data di vendita approssimativa del 03/09/2025 su Nasdaq. La comunicazione specifica che i titoli sono stati acquisiti come Restricted Stock Units il 01/09/2021 (7.000), il 01/09/2022 (4.875), il 01/09/2023 (2.250) e il 01/09/2024 (766). Le azioni in circolazione totali sono 29.278.401. Il dichiarante certifica di non essere a conoscenza di informazioni materiali avverse non divulgate e non segnala vendite negli ultimi tre mesi.

Aviso Form 144 para NVMI muestra una propuesta de venta de 2.220 acciones ordinarias a través de Oppenheimer & Co. Inc., con un valor de mercado agregado de 526.495,20 y una fecha de venta aproximada del 03/09/2025 en Nasdaq. La presentación identifica que los valores fueron adquiridos como Restricted Stock Units el 01/09/2021 (7.000), 01/09/2022 (4.875), 01/09/2023 (2.250) y 01/09/2024 (766). Las acciones en circulación totales son 29.278.401. El declarante certifica que no tiene conocimiento de información material adversa no divulgada y no informa ventas en los últimos tres meses.

NVMI� 대� Form 144 통지� Oppenheimer & Co. Inc.� 통해 2,220 보통주를 매도� 예정임을 보여주며, � 시가총액은 526,495.20이고 대략적� 매각 예정일은 2025� 9� 3�(Nasdaq)입니�. 제출서에� 해당 증권� Restricted Stock Units� 취득되었음이 명시되어 있으� 취득일은 2021-09-01(7,000), 2022-09-01(4,875), 2023-09-01(2,250), 2024-09-01(766)입니�. � 발행주식수는 29,278,401주입니다. 제출인은 공개되지 않은 중대� 불리� 정보가 없음� 증명하며 지� 3개월� 매도� 보고하지 않았습니�.

Avis Form 144 pour NVMI indique une vente proposée de 2 220 actions ordinaires via Oppenheimer & Co. Inc., pour une valeur de marché globale de 526�495,20 et une date de vente approximative au 03/09/2025 sur le Nasdaq. Le dépôt précise que les titres ont été acquis en tant que Restricted Stock Units le 01/09/2021 (7 000), le 01/09/2022 (4 875), le 01/09/2023 (2 250) et le 01/09/2024 (766). Le nombre total d'actions en circulation est de 29 278 401. Le déclarant certifie ne pas avoir connaissance d'informations défavorables matérielles non divulguées et ne signale aucune vente au cours des trois derniers mois.

Form 144-Mitteilung für NVMI zeigt einen geplanten Verkauf von 2.220 Stammaktien über Oppenheimer & Co. Inc. mit einem Gesamtmarktwert von 526.495,20 und einem ungefähren Verkaufsdatum am 03.09.2025 an der Nasdaq. Die Einreichung gibt an, dass die Wertpapiere am 01.09.2021 (7.000), 01.09.2022 (4.875), 01.09.2023 (2.250) und 01.09.2024 (766) als Restricted Stock Units erworben wurden. Die insgesamt ausstehenden Aktien betragen 29.278.401. Der Einreicher bestätigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und meldet keine Verkäufe in den letzten drei Monaten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does NVMI's Form 144 disclose?

The form discloses a proposed sale of 2,220 ordinary shares through Oppenheimer & Co. Inc., aggregate market value 526,495.20, approximate sale date 09/03/2025.

How were the NVMI shares being sold acquired?

The shares were acquired as Restricted Stock Units on 09/01/2021 (7,000), 09/01/2022 (4,875), 09/01/2023 (2,250), and 09/01/2024 (766).

Did the filer report any sales in the past three months for NVMI?

No. The form states Nothing to Report for securities sold during the past three months.

On which exchange is the proposed NVMI sale expected to occur?

The proposed sale is listed with the Nasdaq exchange as the named securities exchange.

How many NVMI shares were outstanding per the filing?

The filing lists 29,278,401 shares outstanding.
Nova Ltd

NASDAQ:NVMI

NVMI Rankings

NVMI Latest News

NVMI Latest SEC Filings

NVMI Stock Data

7.14B
29.40M
77.24%
5.04%
Semiconductor Equipment & Materials
Technology
Israel
Rehovot